CMV's hidden impact on transplant immunity under the microscope

NCT ID NCT06976008

Not yet recruiting Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how CMV (a common virus) changes the immune system in people who have had a kidney transplant. Researchers will take blood samples from 60 patients to compare immune responses in those with and without CMV infection. The goal is to understand why CMV may increase the risk of other infections after transplant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better manage infection risks in kidney transplant patients by understanding how CMV affects immunity.
What could go wrong: This is an observational study with only 60 participants, so results may not apply to all patients. It aims to gather knowledge, not test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cytomegalovirus infection end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY TRANSPLANTATION

Contacts and locations

Locations

Hôpital Bicêtre

Le Kremlin-Bicêtre, 94270, France
Hôpital Necker-Enfants Malades

Paris, 75015, France
Hôpital européen Georges Pompidou

Paris, 75015, France
Insitut Pasteur

Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.